个性化整合多学科治疗方案对难治性儿童特应性皮炎治疗成功的预测因素
本研究针对按现行指南治疗似乎无效的难治性特应性皮炎儿童,评估6周个性化整合多学科治疗方案(PIM)后6个月的长期治疗成功情况。79名8-18岁儿童完成PIM,74名有长期随访数据,77%获得长期治疗成功。母亲疾病接纳度(调整OR 1.84,95%CI 1.15-2.94)预测成功,而一组以女性为主(OR 0.10,95%CI 0.02-0.54)、多种躯体主诉(OR 0.88,95%CI 0.80-0.97)、母亲对局部糖皮质激素使用焦虑(OR 0.62,95%CI 0.40-0.94)者较难获得长期成功。
要点
- 77%的难治性特应性皮炎儿童在PIM后6个月获得长期治疗成功。
- 母亲疾病接纳度较高者长期治疗成功可能性更高(调整OR 1.84,95%CI 1.15-2.94)。
- 女性为主、多种躯体主诉、母亲对局部糖皮质激素焦虑的一组较难获得长期成功。
核心结论
- 多数按现行指南常规治疗似乎无效的难治性特应性皮炎儿童和青少年可通过PIM获得改善。
- 心理社会和家庭因素而非临床因素预测参与PIM后的长期治疗成功。
研究设计与样本
- 研究为针对8-18岁难治性特应性皮炎儿童和青少年的6周个性化整合多学科治疗方案(PIM)的预测因素分析。
- 共79名儿童/青少年完成PIM,其中74名有长期治疗结果数据。
- 采用多变量逻辑回归模型(向后选择法)分析预测因素;心理社会特征通过问卷评估,临床数据从病历中提取。
主要发现
- 77%的儿童/青少年在PIM结束后6个月获得长期治疗成功。
- 长期治疗成功的预测因素包括母亲疾病接纳度,调整OR(95%CI)为1.84(1.15-2.94)。
- 一组以女性为主(23%)的儿童/青少年较难获得长期治疗成功,其OR(95%CI)为0.10(0.02-0.54)。
- 多种躯体主诉者较难获得长期治疗成功,OR(95%CI)为0.88(0.80-0.97)。
- 来自母亲对局部糖皮质激素使用焦虑家庭的儿童/青少年较难获得长期治疗成功,OR(95%CI)为0.62(0.40-0.94)。
关键数值与推荐
- 治疗成功定义为PIM结束后6个月时自我报告湿疹面积和严重度指数(Self-Administered Eczema Area and Severity Index)较基线降低75%和/或特应性皮炎对日常生活影响很小(儿童皮肤病生活质量指数评分≤6)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A 6-week personalized integrative multidisciplinary treatment programme (PIM) was developed for children with difficult to treat AD who appeared unresponsive to treatment according to current guidelines. OBJECTIVE: The aim of the present study was to identify clinical and psychosocial characteristics that predict long-term treatment success after PIM. METHODS: Treatment was considered successful when there was a 75% reduction on the Self-Administered Eczema Area and Severity Index and/or little impact of AD on daily life, measured with the Children's Dermatology Life Quality Index (score ≤ 6), 6 months after the end of PIM. PIM is a personalized, integrative, multidisciplinary treatment programme with clearly defined goals and strategies, addressing atopic, paediatric, mental health comorbidities and general well-being, for children and adolescents aged 8- to 18 years. Multivariate logistic regression models were constructed using a backward selection procedure. Questionnaires were used to assess psychosocial characteristics; clinical data was extracted from medical records. RESULTS: In total, 79 children/adolescents with difficult to treat AD completed PIM and long-term treatment results were available for 74 children/adolescents. The majority (77%) of children/adolescents demonstrated long-term treatment success with PIM. Predictors of long-term treatment success (adjusted ORs) included maternal disease acceptance OR (95% CI) 1.84 (1.15-2.94). A group (23%) of mostly females OR (95% CI) 0.10 (0.02-0.54) with multiple somatic complaints OR (95% CI) 0.88(0.80-0.97), from families where the mother has anxiety for the use of topical corticosteroids OR (95% CI) 0.62(0.40-0.94), is less likely to obtain long-term treatment success. CONCLUSION: Most children and adolescents with difficult to treat AD, seemingly unresponsive to conventional treatment according to current guidelines, are able to improve with PIM. Psychosocial and family but not clinical variables, predicted long-term treatment success after participating in PIM.
引用
- Fieten KB, Schappin R, Zijlstra WT, et al. Predictors of treatment success in children with difficult to treat atopic dermatitis using a personalized integrative multidisciplinary (PIM) treatment programme. J Eur Acad Dermatol Venereol. 2018. PMID: 30198582. doi:10.1111/jdv.15244
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。